Gene Therapy

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

2 days ago   |   Xconomy

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug...
Read more ...

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

Emendo Biotherapeutics Nabs $61M for “Next-Generation CRISPR” R&D

3 days ago   |   Xconomy

Emendo Biotherapeutics, a company aiming to apply CRISPR gene editing to a wider range of genetic diseases, has raised $61 million in financing. The Series B round was led by...
Read more ...

Angiocrine Bioscience, Inc.: Exec. Dir/V.P. - Medical & Clinical Development, Regenerative Medicine and Gene Therapy

5 days ago   |   San Diego Biotechnology

Angiocrine Bioscience, Inc.: Serve as medical leader for our RM & GT programs to transform medicine through cellular therapies that restore, regenerate and repair tissues. San...
Read more ...

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans

5 days ago   |   Xconomy

JP Morgan's annual healthcare conference convenes in San Francisco this week and Generation Bio CEO Geoff McDonough is betting gene therapy will be among the discussion topics...
Read more ...

Cholesterol‐conjugated PEGylated PAMAM as an efficient nanocarrier for plasmid encoding interleukin‐12 immunogene delivery toward colon cancer cells

8 days ago   |   Wiley

Abstract IL‐12 is a pleiotropic cytokine, which shows an ideal applicant for tumor immunotherapy, because of its features of creating an interconnection between innate and...
Read more ...

Biotech Briefing: UCSD Researchers Find Potential Therapeutic Path for ALS with SOD1 Mutations

9 days ago   |   San Diego Biotechnology

Reports + Research UCSD Researchers Find Potential Therapeutic Path for ALS with SOD1 Mutations A potential gene therapy that silences SOD1 could suppress symptoms, which...
Read more ...

Ultragenyx shares jump on 'better than expected' gene therapy data

9 days ago   |   Fierce Biotech

Ultragenyx Pharmaceutical saw its shares jump around 25% in trading Friday after announcing positive top-line data out of its gene therapy trial.
Read more ...

Solid Bio Restructures to Get Halted Gene Therapy Study Back on Track

Solid Bio Restructures to Get Halted Gene Therapy Study Back on Track

9 days ago   |   Xconomy

Solid Biosciences is slashing its workforce, including two top executives, in order to devote the company's remaining resources to its experimental gene therapy for Duchenne...
Read more ...

Nanoparticles deliver 'suicide gene' therapy to pediatric brain tumors growing in mice

10 days ago   |   ScienceDaily

Researchers report that a type of biodegradable, lab-engineered nanoparticle they fashioned can successfully deliver a ''suicide gene'' to pediatric brain tumor cells implanted...
Read more ...

Dog Study Revives Concerns About Virus Used for Gene Therapy

11 days ago   |   Gene Therapy

Posted on: 7 January 2020, Adeno-associated viruses are popular vectors for delivering gene therapies to patients' cells because, researchers believed, the DNA these viruses...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Revolution Medicines Maps Out an IPO to Reach Cancer's Frontiers

Revolution Medicines Maps Out an IPO to Reach Cancer's Frontiers

Cancer research has revealed proteins known to play a role in the disease, but with no known way of stopping what they do. In pharmaceutical parlance, they're “undruggable.”... Read more ...

AveXis Inc.: Research Associate III

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...

Mirati Therapeutics: Student Assistant

Mirati Therapeutics: Mirati Therapeutics is a targeted oncology company developing an advanced pipeline of breakthrough medicines for precisely defined patient populations San... Read more ...

Inhibition of lignification of Zizania latifolia with radio frequency...

Zizania latifolia is easily lignified after harvesting, leading to the degradation of food quality and commercial value. Thus, this study evaluated the effect of radio... Read more ...

Performance difference of graph-based and alignment-based hybrid error...

The error-prone third-generation sequencing long reads can be corrected by the high-quality second-generation sequencing short reads, which is referred to as hybrid error... Read more ...

CHROMATIX: computing the functional landscape of many-body chromatin...

Chromatin interactions are important for gene regulation and cellular specialization. Emerging evidence suggests many-body spatial interactions play important roles in... Read more ...

Bachem: Validation Engineer II, QA

Bachem: Your Responsibilities The Validation Engineer II fulfills a critical role in GMP operations. This individual must plan and execute validation studies, Vista, CA, US ... Read more ...

AveXis Inc.: Senior Scientist, Molecular Biology

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...

Mirati Therapeutics: Talent Partner

Mirati Therapeutics: Reporting to the Head of Business, Culture and Talent this role will be partner with C-Level executive(s) and their staff. This role will be responsib San... Read more ...

Selective inhibition of matrix metalloproteinase 10 with a single-domain...

Since their discovery, the matrix metalloproteinase family of proteases have been considered as therapeutic targets in numerous diseases and disorders. Unfortunately, clinical... Read more ...